1. Home
  2. DOMH vs ABOS Comparison

DOMH vs ABOS Comparison

Compare DOMH & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMH
  • ABOS
  • Stock Information
  • Founded
  • DOMH 1967
  • ABOS 1996
  • Country
  • DOMH United States
  • ABOS United States
  • Employees
  • DOMH N/A
  • ABOS N/A
  • Industry
  • DOMH Biotechnology: Pharmaceutical Preparations
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOMH Health Care
  • ABOS Health Care
  • Exchange
  • DOMH Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • DOMH 83.3M
  • ABOS 72.7M
  • IPO Year
  • DOMH N/A
  • ABOS 2021
  • Fundamental
  • Price
  • DOMH $5.27
  • ABOS $1.18
  • Analyst Decision
  • DOMH
  • ABOS Strong Buy
  • Analyst Count
  • DOMH 0
  • ABOS 4
  • Target Price
  • DOMH N/A
  • ABOS $6.50
  • AVG Volume (30 Days)
  • DOMH 302.6K
  • ABOS 570.9K
  • Earning Date
  • DOMH 08-07-2025
  • ABOS 08-12-2025
  • Dividend Yield
  • DOMH 6.07%
  • ABOS N/A
  • EPS Growth
  • DOMH N/A
  • ABOS N/A
  • EPS
  • DOMH N/A
  • ABOS N/A
  • Revenue
  • DOMH $24,891,000.00
  • ABOS N/A
  • Revenue This Year
  • DOMH N/A
  • ABOS N/A
  • Revenue Next Year
  • DOMH N/A
  • ABOS N/A
  • P/E Ratio
  • DOMH N/A
  • ABOS N/A
  • Revenue Growth
  • DOMH 630.80
  • ABOS N/A
  • 52 Week Low
  • DOMH $0.83
  • ABOS $0.86
  • 52 Week High
  • DOMH $13.58
  • ABOS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • DOMH 49.52
  • ABOS 50.62
  • Support Level
  • DOMH $5.08
  • ABOS $1.12
  • Resistance Level
  • DOMH $6.08
  • ABOS $1.26
  • Average True Range (ATR)
  • DOMH 0.53
  • ABOS 0.07
  • MACD
  • DOMH -0.04
  • ABOS -0.01
  • Stochastic Oscillator
  • DOMH 25.45
  • ABOS 37.46

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: